Elsevier

Kidney International

Volume 79, Issue 6, 2 March 2011, Pages 583-586
Kidney International

Commentary
Non-HLA antibodies in kidney allograft rejection: convincing concept in need of further evidence

https://doi.org/10.1038/ki.2010.517Get rights and content
Under an Elsevier user license
open archive

Mostly indirect evidence suggests an important pathogenic role for non-HLA anti-endothelial cell antibodies (AECAs) in both acute and chronic rejection. The lack of standardized screening assays for AECAs unfortunately hampers the systematic collection of data in multicenter trials. Diagnostic tests based on commercially available platforms could pave the way for testing larger patient cohorts, but they still suffer from some important limitations.

Cited by (0)

The author declared no competing interests.